(Q37871324)

24 August 2017

title

Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure (English)

1 reference

24 August 2017

Chlamydia pneumoniae

1 reference

1

Bernadette Donath

1 reference

24 August 2017

4

Sigrid Prebeck

1 reference

24 August 2017

5

Nikolaus Jilg

1 reference

24 August 2017

Claudia Fischer

2

1 reference

24 August 2017

Sharon Page

3

1 reference

24 August 2017

Marion Weber

6

1 reference

24 August 2017

Clarissa da Costa

7

1 reference

24 August 2017

Dieter Neumeier

8

1 reference

24 August 2017

Thomas Miethke

9

1 reference

24 August 2017

Korbinian Brand

10

1 reference

24 August 2017

publication date

1 November 2002

1 reference

24 August 2017

1 reference

24 August 2017

volume

165

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

79-88

1 reference

Chlamydia pneumoniae in atherosclerosis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Induction of macrophage foam cell formation by Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Oxidized LDL and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

NF-kappa B: ten years after

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

NF-kappa B: a lesson in family values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

I kappa B proteins: structure, function and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

The IKK complex: an integrator of all signals that activate NF-kappaB?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IkappaB kinase signalsome activation and IkappaB proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Evaluation of culture conditions used for isolation of Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900198-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(02)00198-3

1 reference

24 August 2017

1 reference